2025-04-17
ESHG Pharmacogenomics Course

International Scientific Committee

  • Vita Dolžan, chair (Faculty of Medicine, University of Ljubljana, Slovenia; ESPT, SafePolyMed, PharmGenHub)
  • Magnus Ingelman-Sundberg (Karolinska Institutet, Stockholm, Sweden)
  • William Newman (Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, United Kingdom; ESHG)
  • Cristina Rodriguez-Antona (Spanish National Cancer Research Centre, Madrid, Spain)
  • Ron van Schaik (Erasmus Medical Center, Erasmus University Medical Centre, Rotterdam, The Netherlands; ESPT)
  • Julia C. Stingl (Heidelberg University Hospital, Germany; SafePolyMed)

Local organizing Committee

  • Vita Dolžan, chair
  • Katja Goričar
  • Tanja Blagus
  • David Vogrinc
  • Teja Muha

Endorsed and supported by

European Society of Human Genetics - ESHG

European Society of Pharmacogenomics and Personalised Therapy - ESPT

HORIZON-HLTH-2021-CARE-05 project: Improving Safety in Polymedication by Managing Drug-Drug-Gene Interactions - SafePolyMed (GA No. 101057639)

HORIZON-WIDERA-2021-ACCESS-02 project: Pharmacogenomics Hub in a strengthened IMGGE - PharmGenHUB (GA No. 101059870)



Organizational support

ANTANA PCO

2006 - Univerza v Ljubljani, Medicinska fakulteta, Institut za biokemijo.